Medium materiality6/10
Raymond James Upgrades Tvardi Therapeutics Inc (TVRD) to Outperform
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
TVRD is upgraded to Outperform by Raymond James with a $10 target; current price is $9.26.
- TVRD: Raymond James Outperform target $10; price $9.26.
Key facts
- 01
Target: $10
- 02
Posted price: $9.26
- 03
Analyst firm: Raymond James
- 04
Analyst: Ryan Deschner
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.